Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2020

Aug 5, 2020

29841_dirs_2020-08-05_b08a4f1f-83d1-4e88-a7a9-9c77f3d005a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-08-03

Reporting Person: COYLE MICHAEL J (EVP & Group Pres, Cardiac&Vasc)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-03 Ordinary Shares A 9453 Acquired 190563 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-03 Stock Option (Right to Buy) $97.33 A 86901 Acquired 2030-08-03 Ordinary Shares (86901) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 1575 Acquired 2030-08-03 Ordinary Shares (1575) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 49118 Acquired 2030-08-03 Ordinary Shares (49118) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 250 Indirect
Ordinary Shares 4104 Indirect

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.